Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NetraMark HoldingsAINMF 31 Receivables Turnover is 0.17 as of Mar. 2026. GuruFocus rates AINMF with a GF Score™ of 31/100 and a GF Value™ of $0.21 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 661 Healthcare Providers & Services companies, NetraMark Holdings ranks worse than 89.56% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. NetraMark Holdings's Revenue for the
three
months ended in Mar. 2026 was $0.01 Mil. NetraMark Holdings's average Accounts Receivable for the
three
months ended in Mar. 2026 was $0.05 Mil.
Hence, NetraMark Holdings's Receivables Turnover for the
three
months ended in Mar. 2026 was 0.17.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
NetraMark Holdings Receivables Turnover Related Terms
NetraMark Holdings Receivables Turnover Historical Data
* Premium members only.
The historical data trend for NetraMark Holdings's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AINMF vs VEEV, BTSG, TEM: Receivables Turnover Comparison
For the Health Information Services subindustry, NetraMark Holdings's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NetraMark Holdings Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NetraMark Holdings's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where NetraMark Holdings's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NetraMark Holdings (AINMF) has a Receivables Turnover of 0.17 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on NetraMark Holdings and its competitors. According to the industry distribution chart, NetraMark Holdings ranks #592 out of 661 companies in the Healthcare Providers & Services industry, placing it in the top 89.6%.
Is NetraMark Holdings' Receivables Turnover too high?
NetraMark Holdings' current Receivables Turnover is 0.17. The Healthcare Providers & Services industry median Receivables Turnover is 7.74. NetraMark Holdings' value of 0.17 is 97.8% below this industry median. Based on the distribution chart, NetraMark Holdings ranks #592 out of 661 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, NetraMark Holdings has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NetraMark Holdings' Receivables Turnover compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, NetraMark Holdings ranks #592 out of 661 companies for Receivables Turnover. This places NetraMark Holdings in the lower half of its industry. The industry median Receivables Turnover is 7.74. NetraMark Holdings' value of 0.17 is 97.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.74, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NetraMark Holdings's current Receivables Turnover of 0.17 is 97.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on NetraMark Holdings and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NetraMark Holdings's current Receivables Turnover is 0.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NetraMark Holdings stock overvalued right now?
Based on GuruFocus' analysis, NetraMark Holdings (AINMF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.21, compared to a current price of $0.66 — trading 213.4% above its estimated fair value. The current Receivables Turnover is 0.17 and 97.8% below the Healthcare Providers & Services industry median of 7.74. NetraMark Holdings' overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For NetraMark Holdings (AINMF), the current Receivables Turnover is 0.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NetraMark Holdings (AINMF) Overvalued in 2026?
Based on GuruFocus' analysis, NetraMark Holdings stock appears to be overvalued.
The current stock price of $0.66 is trading 213.4% above its estimated GF Value™ of $0.21.
GuruFocus considers NetraMark Holdings to be Significantly Overvalued.
Key valuation signals for AINMF:
Receivables Turnover: 0.17
GF Value™: $0.21 vs. price of $0.66 (213.4% above fair value)
Industry Position: 97.8% below the Healthcare Providers & Services median (#592 of 661)
No single metric tells the full story. See the AINMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NetraMark Holdings Inc provides AI-powered insights and software solutions to optimize clinical trial design and outcomes for pharmaceutical sponsors. The company offers AI solutions to trial sponsors, CROs, and biotechnology companies across the globe. It earns revenue from its proprietary NetraAI platform, an advanced machine learning system purpose-built to analyze complex clinical trial data and identify meaningful patient subpopulations.
31GF Score
Get the complete analysis for AINMF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AINMF has been successfully added to your 
